Revivewell Pharmaceuticals Private Limited
About Revivewell Pharmaceuticals Private Limited
Data last updated:
Revivewell Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It was incorporated on 11 August 2023.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U46497TS2023PTC175962.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Tambali Suvarna and Mohammed Irfan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹15.93 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹48,340 (net margin 3%) and EBITDA of ₹65,324 (EBITDA margin 4.1%).
As per MCA filings, the company has open charges of ₹16.15 Lakh on record.
Company details
Contact details
Revivewell Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana.
- Registered Address4 – 35 – 97 Flat No 302, Manga Residency Madhava, Hyderabad, Telangana, India – 500072
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Revivewell Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Revivewell Pharmaceuticals Private Limited, buy the company report.
Financials of Revivewell Pharmaceuticals Private Limited
FY 2025 filings availableRevivewell Pharmaceuticals Private Limited reported revenue of ₹15.93 Lakh (up 232% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 232% in the latest year. EBITDA rose 172% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹65,324 | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹48,340 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 4.1% | |
| Net Profit Margin | 3% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Revivewell Pharmaceuticals Private Limited, buy the company report.
Board of directors of Revivewell Pharmaceuticals Private Limited
Revivewell Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Tambali Suvarna | Director | 11 Aug 2023 | 3 Years 2 Months | Current |
| Mohammed Irfan | Director | 11 Aug 2023 | 3 Years 2 Months | Current |
| Sri Ramachandra Murthy Kolavennu | Director | 11 Aug 2023 | 3 Years 2 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 18 Oct 2025 | 101185251 | Hdfc Bank Limited | ₹16.15 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Revivewell Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Revivewell Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Revivewell Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Revivewell Pharmaceuticals Private Limited has 3 board changes on record since 2023: 3 appointments. The latest: Mohammed Irfan was appointed as Director on 11 Aug 2023.
Frequently asked questions
Revivewell Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. It was incorporated on 11 August 2023 (3+ years old) and is registered under CIN U46497TS2023PTC175962.
Revivewell Pharmaceuticals has 3 current directors:
- Tambali Suvarna - Director
- Mohammed Irfan - Director
- Sri Ramachandra Murthy Kolavennu - Director
The latest financial statements of Revivewell Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Revivewell Pharmaceuticals is U46497TS2023PTC175962. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Revivewell Pharmaceuticals was incorporated on 11 August 2023, making it 3+ years old. It is registered with the Registrar of Companies, Hyderabad.
Mohammed Irfan was appointed as Director on 11 Aug 2023. Sri Ramachandra Murthy Kolavennu was appointed as Director on 11 Aug 2023. Tambali Suvarna was appointed as Director on 11 Aug 2023.
The registered office of Revivewell Pharmaceuticals is at 4 – 35 – 97 Flat No 302, Manga Residency Madhava, Hyderabad, Telangana, India – 500072.
Revivewell Pharmaceuticals has open charges of ₹16.15 Lakh and no satisfied charges on record as per latest MCA filings.
Revivewell Pharmaceuticals can be reached at its registered office: 4 – 35 – 97 Flat No 302, Manga Residency Madhava, Hyderabad, Telangana, India – 500072.
Revivewell Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Hyderabad.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
